Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. COSMOS Pharmaceutical Corporation
  6. News
  7. Summary
    3349   JP3298400007

COSMOS PHARMACEUTICAL CORPORATION

(3349)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Topix closes at near one-month high as investors await earnings

07/13/2021 | 02:47am EDT

TOKYO, July 13 (Reuters) - Japanese stocks gained on Tuesday, with the broad Topix index hitting a near one-month high, after markets recovered from last week's sell-off and awaited a slew of corporate earnings for a fresh readout on the country's economic health.

Nikkei share average closed 0.52% higher at 28,718.24, while the broader Topix gained 0.73% to 1,967.64, its highest close since June 16.

Both indexes have quickly recovered from last week's tumble, which many investors attributed to concerns over Delta variant as well as big selling from Exchange Traded Funds (ETFs) related to their dividend payment.

U.S. earnings season kicked off this week and many Japanese companies are expected to announce their quarterly numbers from this month-end until mid-August, making earnings the main focus of the market.

A broad range of stocks gained, with all but four of the Tokyo Stock Exchange's 33 industry sub-indexes trading in the black.

Cyclical, value-oriented shares led the gains, including shippers, securities brokerages, and insurers.

Value-oriented shares outperformed with gains of 1.1%, compared with a 0.4% rise in growth shares.

"I am a bit cautious about the outlook, though. Growth shares are expensive and it will take some time before their earnings will catch up with expectations. On the other hand, value shares have risen over the past seven months or so and looking at the past their rally has not lasted longer than that," Takenori Yamamoto, portfolio manager at Norinchukin Zenkyoren Asset Management said.

Tama Home soared 17.6% to its record high after the home builder posted upbeat earnings due to stronger post-pandemic demand.

Cosmos Pharmaceutical gained 9.3% after the drugstore chain operator posted forecast-beating earnings.

Kakuyasu dropped 3.3% after the alcohol retailer withdrew its earnings outlook for the current year through March 2022, citing uncertainties due to the government's renewed bans on alcohol being served in restaurants. (Reporting by Hideyuki Sano, Editing by Sherry Jacob-Phillips)


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
COSMOS PHARMACEUTICAL CORPORATION -0.59% 20290 End-of-day quote.21.64%
KAKUYASU GROUP CO., LTD. 0.00% 1970 End-of-day quote.22.44%
TAMA HOME CO., LTD. -0.43% 2792 End-of-day quote.89.67%
All news about COSMOS PHARMACEUTICAL CORPORATION
07/13Topix closes at near one-month high as investors await earnings
RE
05/28COSMOS PHARMACEUTICAL CORPORATION : Ex-dividend day for final dividend
FA
2020COSMOS PHARMACEUTICAL CORPORATION : Ex-dividend day for interim dividend
FA
2020COSMOS PHARMACEUTICAL CORPORATION : SPLIT: 2 of 1
FA
2020COSMOS PHARMACEUTICAL CORPORATION : Ex-dividend day for final dividend
FA
2019COSMOS PHARMACEUTICAL CORP : Ex-dividend day for interim dividend
FA
2019COSMOS PHARMACEUTICAL CORP : Ex-dividend day for final dividend
FA
2018COSMOS PHARMACEUTICAL CORP : Ex-dividend day for interim dividend
FA
2018COSMOS PHARMACEUTICAL CORP : Ex-dividend day for final dividend
FA
2018Hidefuji Co., Ltd. acquired 5.25% stake in COSMOS Pharmaceutical Corporation from Masat..
CI
More news
Financials
Sales 2022 763 B 6 922 M 6 922 M
Net income 2022 25 267 M 229 M 229 M
Net cash 2022 59 063 M 536 M 536 M
P/E ratio 2022 31,8x
Yield 2022 0,35%
Capitalization 803 B 7 293 M 7 291 M
EV / Sales 2022 0,98x
EV / Sales 2023 0,89x
Nbr of Employees -
Free-Float 47,3%
Chart COSMOS PHARMACEUTICAL CORPORATION
Duration : Period :
COSMOS Pharmaceutical Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COSMOS PHARMACEUTICAL CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 20 290,00 JPY
Average target price 18 484,62 JPY
Spread / Average Target -8,90%
EPS Revisions
Managers and Directors
Hideaki Yokoyama President & Representative Director
Masateru Uno Chairman
Masahiro Iwashita Executive Officer & Manager-Information Systems
Masao Ueda Independent Outside Director
Futoshi Shibata Director & Manager-Corporate Planning
Sector and Competitors